As per the data released by the Department of Industrial Policy and Promotion (D IPP), the drugs and pharmaceuticals

sector has attracted foreign direct investme nt (FDI) worth US$ 2.4 billion between April 2000 and April 2011, while hospital s and diagnostic centres have received FDI worth US$ 1.03 billion in the same pe riod. Biotech-The sunrise sector is expected to touch the US$10 billion mark by 2015 o n the back of emerging opportunities across various verticals, namely biopharma, agri-biotechnology, industrial biotechnology among others. The Indian biotech i ndustry clocked revenues worth US$ 4 billion in 2010-11, witnessing a 33 per cen t growth over the previous year. Of these revenues, around 40 per cent is contri buted by Karnataka. In the overall revenue of US$ 3 billion (2010), exports acco unted for 53 per cent of the share

The Government has increased the plan allocation for the public health spending to US$ 5.96 billion in 2011-12 from US$ 4.97 billion in 2010-11 and US$ 4.35 bil lion in 2009-10 respectively.

India s pharmaceutical industry is the third largest in the world in terms of volu me and stands 14th in terms of value. The domestic pharma sector continued its s trong show in 2010 and recorded a 16.5 per cent growth during January-December. India will join the league of top 10 global pharmaceuticals markets in terms of sales by 2020 with the total value reaching USD 50 billion by then, according to a report by PricewaterhouseCoopers (PwC)

The Indian pharmaceutical industry forms around 8 per cent of world pharmaceutic al production

The Indian Pharmaceutical market is poised to grow to US$ 55 billion by 2020 fro m the 2009 levels of US$ 12.6 billion, as per a report by McKinsey & Company. Th e industry further holds potential to reach US$ 70 billion, at a compound annual growth rate (CAGR) of 17 per cent.

India's exports (Pharma) till November 2010 -US$ 763.62 million Growth rate of 9 %

The Indian generic drug market is expected to grow at a CAGR of around 17 per ce nt between 2010-11 and 2012-13.

100 per cent foreign direct investment (FDI) is permitted under the automatic ro ute in the drugs and pharmaceuticals sector including those involving use of rec ombinant technology

Ten multinational companies (MNCs) - accounted for 25.4 per cent, or US$ 2.6 bil lion, of the US$ 10.6 billion domestic pharmaceutical market in 2010, according to IMS India.